Cargando…
Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms
BACKGROUND: There are increasing reports of early externally mounted pericardial Trifecta bioprosthesis failure. We compared the hemodynamic performance of Trifecta and Carpentier–Edwards Perimount Magna Ease valves to determine the failure mechanism. METHODS: We retrospectively included 270 consecu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373186/ https://www.ncbi.nlm.nih.gov/pubmed/35603636 http://dx.doi.org/10.1177/02184923221100994 |
_version_ | 1784767547728461824 |
---|---|
author | Suzuki, Ryo Ito, Toshiro Suzuki, Masato Ohori, Shunsuke Takayanagi, Ryo Miura, Shiro |
author_facet | Suzuki, Ryo Ito, Toshiro Suzuki, Masato Ohori, Shunsuke Takayanagi, Ryo Miura, Shiro |
author_sort | Suzuki, Ryo |
collection | PubMed |
description | BACKGROUND: There are increasing reports of early externally mounted pericardial Trifecta bioprosthesis failure. We compared the hemodynamic performance of Trifecta and Carpentier–Edwards Perimount Magna Ease valves to determine the failure mechanism. METHODS: We retrospectively included 270 consecutive patients (age: 73.4 ± 8.2 years; 57.5% male; mean follow-up: 48.0 ± 20.3 months) who underwent aortic valve replacement from 2014 to 2021 at a single center and compared the Trifecta (N = 137) and Carpentier–Edwards Perimount Magna Ease valve (N = 133) patients. RESULTS: The prosthetic valve major aortic regurgitation incidence was higher for the Trifecta than that for the Carpentier–Edwards Perimount Magna Ease valve (6.3% vs. 0%, P < 0.009). Among the Trifecta failures, 33% developed structural valve deterioration, but all requiring redo aortic valve replacement developed major prosthetic valve aortic regurgitation. Freedom at 5 years from redo aortic valve replacement due to structural valve deterioration was significantly lower for Trifecta (89.4% vs. 100%, P = 0.003). The reoperation hazards were determined for Trifecta (vs. Carpentier–Edwards Perimount Magna Ease): 11.6 (1.47–90.9; P = 0.02), prosthetic valve aortic regurgitation: 2.38 (1.70–3.32; P < 0.01), structural valve deterioration: 20.82 (4.08–106.2; P < 0.01), 5-year mean transprosthetic pressure gradient: 1.14 per 1-point increase (1.03–1.24; P = 0.007), and urgent surgery: 10.1 (2.59–39.0; P = 0.001). The Cox regression analysis identified that prosthetic valve aortic regurgitation solely contributed to redo aortic valve replacement (hazard ratio: 2.38; confidence intervals: 1.70–3.32). CONCLUSIONS: Significantly, more early failures occurred with the Trifecta valve than the Carpentier–Edwards Perimount Magna Ease valve but the Trifecta showed reasonable mean transprosthetic pressure gradient over time. Prosthetic valve aortic regurgitation and calcific structural valve deterioration synergistically contributed to Trifecta valve failure alternatively. |
format | Online Article Text |
id | pubmed-9373186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-93731862022-08-13 Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms Suzuki, Ryo Ito, Toshiro Suzuki, Masato Ohori, Shunsuke Takayanagi, Ryo Miura, Shiro Asian Cardiovasc Thorac Ann Original Articles BACKGROUND: There are increasing reports of early externally mounted pericardial Trifecta bioprosthesis failure. We compared the hemodynamic performance of Trifecta and Carpentier–Edwards Perimount Magna Ease valves to determine the failure mechanism. METHODS: We retrospectively included 270 consecutive patients (age: 73.4 ± 8.2 years; 57.5% male; mean follow-up: 48.0 ± 20.3 months) who underwent aortic valve replacement from 2014 to 2021 at a single center and compared the Trifecta (N = 137) and Carpentier–Edwards Perimount Magna Ease valve (N = 133) patients. RESULTS: The prosthetic valve major aortic regurgitation incidence was higher for the Trifecta than that for the Carpentier–Edwards Perimount Magna Ease valve (6.3% vs. 0%, P < 0.009). Among the Trifecta failures, 33% developed structural valve deterioration, but all requiring redo aortic valve replacement developed major prosthetic valve aortic regurgitation. Freedom at 5 years from redo aortic valve replacement due to structural valve deterioration was significantly lower for Trifecta (89.4% vs. 100%, P = 0.003). The reoperation hazards were determined for Trifecta (vs. Carpentier–Edwards Perimount Magna Ease): 11.6 (1.47–90.9; P = 0.02), prosthetic valve aortic regurgitation: 2.38 (1.70–3.32; P < 0.01), structural valve deterioration: 20.82 (4.08–106.2; P < 0.01), 5-year mean transprosthetic pressure gradient: 1.14 per 1-point increase (1.03–1.24; P = 0.007), and urgent surgery: 10.1 (2.59–39.0; P = 0.001). The Cox regression analysis identified that prosthetic valve aortic regurgitation solely contributed to redo aortic valve replacement (hazard ratio: 2.38; confidence intervals: 1.70–3.32). CONCLUSIONS: Significantly, more early failures occurred with the Trifecta valve than the Carpentier–Edwards Perimount Magna Ease valve but the Trifecta showed reasonable mean transprosthetic pressure gradient over time. Prosthetic valve aortic regurgitation and calcific structural valve deterioration synergistically contributed to Trifecta valve failure alternatively. SAGE Publications 2022-05-22 2022-09 /pmc/articles/PMC9373186/ /pubmed/35603636 http://dx.doi.org/10.1177/02184923221100994 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Suzuki, Ryo Ito, Toshiro Suzuki, Masato Ohori, Shunsuke Takayanagi, Ryo Miura, Shiro Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms |
title | Trifecta versus Perimount Magna Ease aortic valves: Failure
mechanisms |
title_full | Trifecta versus Perimount Magna Ease aortic valves: Failure
mechanisms |
title_fullStr | Trifecta versus Perimount Magna Ease aortic valves: Failure
mechanisms |
title_full_unstemmed | Trifecta versus Perimount Magna Ease aortic valves: Failure
mechanisms |
title_short | Trifecta versus Perimount Magna Ease aortic valves: Failure
mechanisms |
title_sort | trifecta versus perimount magna ease aortic valves: failure
mechanisms |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373186/ https://www.ncbi.nlm.nih.gov/pubmed/35603636 http://dx.doi.org/10.1177/02184923221100994 |
work_keys_str_mv | AT suzukiryo trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms AT itotoshiro trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms AT suzukimasato trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms AT ohorishunsuke trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms AT takayanagiryo trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms AT miurashiro trifectaversusperimountmagnaeaseaorticvalvesfailuremechanisms |